Semaglutide Headache: Why It Happens and How to Handle It

Step 1 — Understand what's most likely driving the headache

Semaglutide slows gastric emptying and reduces appetite, often quite sharply in the early weeks. The practical result is that many people eat and drink noticeably less than usual, sometimes without realising how much less. Mild dehydration alone is a well-established trigger for tension-type headaches, and a reduced calorie intake can push blood-sugar levels lower than the body is accustomed to. Both of these can arrive together, especially in the 24–72 hours after an injection when the medicine's effect on appetite is strongest.

The NHS semaglutide medicines page lists headache among the common side effects reported in clinical studies, alongside nausea, fatigue and dizziness, a cluster that shares this same dehydration-and-reduced-intake mechanism. If you want a closer look at how this plays out specifically with Wegovy, our page on what causes a Wegovy headache and how to manage it goes into more detail. That distinction matters because it points clearly to what helps.

Practical steps worth trying: aim to drink water steadily through the day rather than in large bursts, prioritise protein and complex carbohydrates at mealtimes even when appetite is low, and rest in a cool room if a headache does develop. Paracetamol is generally considered appropriate for mild headache in adults, but check with your prescriber or pharmacist if you take other medicines regularly, since interactions vary.

Step 2, Map the timing: injection-day headache vs. persistent headache

Timing is one of the more useful clues. A headache that arrives within 24–48 hours of your weekly injection and fades by day three or four fits the pattern seen with Wegovy's side-effect profile more broadly, early, predictable, and tied to the appetite-suppression peak. This pattern is especially common when starting treatment or when moving up to a higher dose.

A headache that persists throughout the week, recurs every week at similar intensity, or is getting worse over successive injections is a different matter. That warrants a conversation with your prescriber rather than continued self-management. The same applies if the headache comes paired with severe nausea, vomiting that stops you keeping fluids down, or any sign of significant dehydration such as dark urine or dizziness on standing.

People who have a history of migraines sometimes find that the nausea associated with semaglutide can trigger their usual pattern. If you have pre-existing migraine, flag it during your consultation, it does not automatically disqualify you, but your prescriber will want to factor it in when assessing suitability and monitoring your early weeks on treatment. You can read more about how headaches and semaglutide interact across different patients, including how individual timing after an injection tends to play out, on our headache after a Wegovy shot page.

Step 3, Recognise the signs that need medical attention today

Most headaches on semaglutide are benign and self-limiting. A small number of headaches are not, and it is important to be clear about the difference. Seek prompt medical help (same day, or 999 if severe) if you experience any of the following alongside a headache: sudden, unusually severe or "thunderclap" onset; visual disturbance, slurred speech, one-sided weakness or numbness; a stiff neck with sensitivity to light; or a headache that follows a fall or head injury.

None of these are typical semaglutide side effects, but they are symptoms that should never be attributed to a medicine and waited out. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines focused on acute pancreatitis (characterised by severe pain in the upper abdomen that can radiate to the back, sometimes with vomiting) as a distinct and serious risk to be aware of. Severe abdominal pain is not the same as a headache, but the principle is the same: persistent, unusual or severe symptoms need clinical assessment, not reassurance from a webpage.

If you are uncertain whether what you are experiencing is within normal range, contact your prescriber or pharmacist. At nume, our support team is available seven days a week for exactly this kind of question. Suspected side effects can also be logged directly via the MHRA Yellow Card scheme, which helps build the national safety picture for newer medicines.

Step 4 (Where semaglutide fits and what comes next

Semaglutide) licensed in the UK for weight management as Wegovy, is a prescription-only medicine requiring clinical assessment before it can be dispensed. At nume, a GPhC-registered Independent Prescriber reads every consultation personally; no automated system makes that call. If headaches or other side effects are part of your history, that is exactly the kind of detail a prescriber needs to weigh up before approving treatment and when reviewing it each time you reorder.

The headache side effect, for most people, does not last. Clinical trial data from the STEP programme, published in the New England Journal of Medicine, showed that GI and related symptoms including headache were most pronounced in the early titration phase and tended to diminish as participants reached their maintenance dose. Understanding the cost picture is a reasonable next step once you have decided the treatment is right for you, our Wegovy pricing page covers what is included in the price. If you'd like to explore whether semaglutide is clinically suitable for you, our prescribers cover all of this during the free consultation at the treatment page.